Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The U.S. house should pass the MORE Act no problem, especially where it’s being sponsored by the incoming VP elect Sen. Kamala Harris. Then if the Democrats can overturn the Senate in the Georgia runoffs on Jan. 5th, a real possibility, it could become the law of the land by spring 2021.
A lot more upside left in this beast!
Good luck, I’m holding for $200-300.
Short squeeze is coming soon! This could be a $200 stock with their pipeline.
Hillary was ahead in the polls right up until Election Day in 2016 so, even though it looks very promising, we still need to wait for the results.
Back in again at 5.12. Mars is in opposition, getting ready to blast off!
Market Chatter: Moderna to Seek EU Approval of COVID-19 Vaccine Candidate Based on Real-Time Data
BY MT NEWSWIRES — 10/09/2020
06:16 AM EDT, 10/09/2020 (MT Newswires) -- Moderna (MRNA) will seek approval of its COVID-19 vaccine candidate in Europe based on real-time data from its clinical study, Reuters reported late Thursday.
Such reviews are a relatively faster path to approval, as they allow companies to submit real-time data instead of waiting for the study to be completed first.
Moderna (MRNA) will submit to European regulators the same data it plans to present to the US Food and Drug Administration, the report said.
This would resolve all the issues around transporting long distances below 0 degrees F. Will be huge savings for Moderna.
It seems like the short sellers have taken over this board. Time to wake up people! This is going to be a blockbuster in the near future.
Thanks for tanking the stock market today Donald. Expecting bounce back tomorrow as he walks back his tweet.
https://www.google.com/amp/s/www.fool.com/amp/investing/2020/10/03/is-now-a-good-time-to-buy-moderna-stock/
“But while finishing first is grand, it's not as important as getting an FDA-approved vaccine. Distribution of that vaccine will be another challenge, as there's significant demand all around the world -- too much for a single vaccine maker to fill right out of the gate. Whether Moderna is the first or second company with an approved vaccine may prove to be irrelevant, as there will still likely be strong sales to follow.“
Lol, I’m looking forward to seeing some test results for covi-stix. This company has got so much potential it’s hard to imagine anyone shorting it right now.
Abbott’s still has to be administered by a medical professional requiring what many people, myself included, find to be a very uncomfortable nasal swab. Sorrento’s only requires giving a saliva sample in a cup.
https://sorrentotherapeutics.com/research/covid-19/covi-trace/
Could be a federal grant coming as well.
Great news! Love to see a $500 mil federal grant to go with it.
Those are good questions which I wish I had the answers to but I think the sp dumped in mid August on news of the CFO getting fired. It might help if they actually filed for the EUA.
It’s more about Covi-trace, the saliva test, than Covi-track IMO. Waiting for EUA filing.
Asking for a federal grant? Could this be a prelude to an upcoming EUA?
Great post dia76!
Awesome presentation yesterday. This drop has to do with the dilution from the Smartpharm acquisition. Already getting a bounce. Expecting major catalysts soon.
Covi-Trace is better.
“The test can't be self administered, but a wide range of practitioners, including doctors, nurses, school nurses, medical assistants and technicians, pharmacists and employer occupational health specialists, are able to run the test.
The BinaxNOW COVID-19 Ag Card test isn't perfect. It has a sensitivity of 97.1%, meaning 2.9% of positive cases will be missed, and a specificity of 98.5%, meaning 1.5% of people will test positive even though they don't have COVID-19. “
Why is this down in premarket? Sorrento is in the process of developing covi-shield and covi-guard, neutralizing antibodies derived from convalescent blood plasma, in collaboration with Mount Sinai Health System. I’m expecting an EUA any time now after Trump’s press conference. Time to buy more.
I know Mr. Ji doesn’t usually give PRs but now would certainly be a good time to reassure investors that their finances are in order, especially at this critical juncture in the company’s development.
Does anyone want to try the Russian vaccine? No thank you.
Actually there was animal testing: https://www.google.com/amp/s/www.nytimes.com/2020/07/28/health/coronavirus-moderna-vaccine-monkeys.amp.html
They need to come out with a PR soon to clear up this controversy over the $60 per treatment course.
That Bloomberg article is really a false narrative. The only thing that matters is if the vaccine has enough antibodies to prevent infection, not whether it has more antibodies or less antibodies than any other vaccine.
All good news and stock is down? Smacks of manipulation before anticipated positive Covid vaccine results. https://www.google.com/amp/s/seekingalpha.com/amp/news/3582254-fda-oks-pfizers-neulasta-biosimilar